In Brief: Selfcare
This article was originally published in The Tan Sheet
Executive Summary
Selfcare: Files registration statement with the Securities & Exchange Commission for a public offering of 2 mil. shares managed by Lehman Brothers, Dillon, Read & Co. and A.G. Edwards & Sons. Selfcare, a manufacturer of "self-test" diagnostics for diabetes, women's health and infectious diseases, went public in a 1.3 mil. share offering completed in August 1996 at $10 per share. The IPO was smaller than hoped for by the Waltham, Mass. firm, which had projected selling 2.7 mil. shares for $12 each. Underwriters for the secondary offering have an over-allotment option covering an additional 300,000 shares...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning